A systematic review and meta-analysis of candesartan and losartan in the management of essential hypertension
Background : Candesartan is a relatively novel antihypertensive agent of the angiotensin receptor blocker (ARB). Several clinical trials have compared candesartan with losartan in the management of essential hypertension. However, systematic assessment of efficacy and safety between candesartan and...
Main Authors: | Zhenfeng Zheng, Huilan Shi, Junya Jia, Dong Li, Shan Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publications
2011-09-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.1177/1470320310391503 |
Similar Items
-
A systematic review and meta-analysis of aliskiren and angiotension receptor blockers in the management of essential hypertension
by: Zhenfeng Zheng, et al.
Published: (2011-06-01) -
Losartan inhibits in vitro platelet activation: comparison with candesartan and valsartan
by: Antonio Núñez, et al.
Published: (2000-06-01) -
A Meta-analysis of antihypertensive effect of telmisartan versus candesartan in patients with essential hypertension
by: Di Zhao, et al.
Published: (2019-01-01) -
Candesartan effectiveness in essential arterial hypertension and renal arterial hypertension
by: N. M. Chikhladze, et al.
Published: (2008-12-01) -
Candesartan in treating hypertension
by: L O Minushkina
Published: (2014-03-01)